BiOasis Technologies Company Top Insiders
| BIOAF Stock | USD 0.0001 0.00 0.00% |
BiOasis Technologies employs about 23 people. The company is managed by 6 executives with a total tenure of roughly 54 years, averaging almost 9.0 years of service per executive, having 3.83 employees per reported executive. Examination of BiOasis Technologies' management performance can provide insight into the company performance.
| Kim Elton Insider Director Marketing |
| Mei Tian Insider VP Research |
BiOasis |
BiOasis Technologies Management Team Effectiveness
The company has return on total asset (ROA) of (0.8058) % which means that it has lost $0.8058 on every $100 spent on assets. This is way below average. BiOasis Technologies' management efficiency ratios could be used to measure how well BiOasis Technologies manages its routine affairs as well as how well it operates its assets and liabilities.BiOasis Technologies Workforce Comparison
biOasis Technologies is number one stock in number of employees category among its peers. The total workforce of Health Care industry is currently estimated at about 326,211. BiOasis Technologies adds roughly 23.0 in number of employees claiming only tiny portion of equities under Health Care industry.
biOasis Technologies Benchmark Summation
Operator |
The output start index for this execution was zero with a total number of output elements of sixty-one. biOasis Technologies Price Series Summation is a cross summation of BiOasis Technologies price series and its benchmark/peer.
BiOasis Technologies Notable Stakeholders
A BiOasis Technologies stakeholder refers to an individual interested in an outcome of the business. Different stakeholders have different interests, and companies such as BiOasis Technologies often face trade-offs trying to please all of them. BiOasis Technologies' stakeholders can have a positive or negative influence on the entity's direction, and there are a lot of executives involved in getting BiOasis Technologies' stock to the level that pleases all shareholders. Keeping track of the stakeholders is a great way to stay on top of things affecting its ongoing price.
| Kim Elton | Director Marketing | Profile | |
| Mei Tian | VP Research | Profile | |
| Graeme Dick | Director Relations | Profile | |
| Doug MBA | Exec Officer | Profile | |
| Dave Jenkins | Chief Officer | Profile | |
| B FTSE | CEO Chairman | Profile |
About BiOasis Technologies Management Performance
The success or failure of an entity such as biOasis Technologies often depends on how effective the management is. BiOasis Technologies management team is responsible for propelling the future growth in the right direction and administering and controlling the business activities and accounting for the results. Ineffective management usually contributes to failure in the company's future performance for all stakeholders equally, but most importantly, for investors. So it is important to measure the effectiveness of BiOasis management before purchasing its stock. In many ways, it's all about finding the answer to one important question - Are they doing the right thing right now? How would we assess whether the BiOasis management is utilizing all available resources in the best possible way? Also, how well is the company doing relative to others in its sector and the market as a whole? The answer can be found by analyzing a few important fundamental indicators such as return on assets and return on equity.
Bioasis Technologies Inc., a development stage biopharmaceutical company, engages in the research and development of products for the diagnosis and treatment of neurological diseases and disorders. Bioasis Technologies Inc. was incorporated in 2006 and is headquartered in New Haven, Connecticut. Bioasis Technologies operates under Biotechnology classification in the United States and is traded on OTC Exchange.
BiOasis Technologies Workforce Analysis
Traditionally, organizations such as BiOasis Technologies use manpower efficiency calculations for various incentive schemes, employee appraisal, or as an initiative to improve the processes. However, it can also be used by investors to make long-term investment decisions. The trends in the profit per employee or revenue per employee are measured by net income or revenue divided by the current number of full-time employees over a given time interval. Because workforce needs differ across sectors, these ratios could be used to compare BiOasis Technologies within its industry.BiOasis Technologies Manpower Efficiency
Return on BiOasis Technologies Manpower
| Revenue Per Employee | 1.6K | |
| Revenue Per Executive | 6.3K | |
| Net Loss Per Employee | 128.7K | |
| Net Loss Per Executive | 493.3K | |
| Working Capital Per Employee | 19K | |
| Working Capital Per Executive | 72.8K |
Complementary Tools for BiOasis Pink Sheet analysis
When running BiOasis Technologies' price analysis, check to measure BiOasis Technologies' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BiOasis Technologies is operating at the current time. Most of BiOasis Technologies' value examination focuses on studying past and present price action to predict the probability of BiOasis Technologies' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BiOasis Technologies' price. Additionally, you may evaluate how the addition of BiOasis Technologies to your portfolios can decrease your overall portfolio volatility.
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Pair Correlation Compare performance and examine fundamental relationship between any two equity instruments |